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This disclosure describes a MRI-compatible bioreactor that 
allows a biological sample to be imaged in culture without 
disrupting or compromising the culture. 
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1. 
MR-COMPATIBLE BOREACTORS AND 
METHODS OF USING 
CROSS REFERENCE TO RELATED 
APPLICATIONS 
This application claims the benefit of priority under 35 
U.S.C. S 119(e) to U.S. Application No. 61/677,039 filed Jul. 
30, 2012. The prior application is incorporated herein by 
reference in its entirety. 
TECHNICAL FIELD 
This disclosure generally relates to bioreactors and, more 
specifically, MRI-compatible bioreactors, and methods of 
using Such bioreactors. 
BACKGROUND 
Magnetic resonance imaging (MRI) can observe structural 
and functional changes associated with cell and tissue devel 
opment, facilitating the use of MRI in translational research 
and clinical trials of tissue engineering. One problem when 
applying MRI to tissue engineering is that samples allocated 
in a test tube for imaging cannot be returned back to incuba 
tors and are, therefore, wasted due to potential contamination. 
In addition, Samples removed from the incubator for imaging 
and, therefore, are not under consistent growth conditions or 
environments. Thus, there is a need for an approach that 
allows the functional outcome of cellor tissue constructs to be 
monitored non-invasively without interrupting or disturbing 
the culture. 
SUMMARY 
This disclosure describes a MRI-compatible bioreactor, 
which allows imaging of a growing biological sample without 
disrupting or disturbing the culture. 
In one aspect, a MRI-compatible bioreactor system is pro 
vided. Such a system generally includes a bioreactor compo 
nent that includes a tissue-imaging chamber and a Support 
chamber. The tissue-imaging chamber and the Support cham 
ber generally are separated by a permeable Support that 
allows for fluid communication between the chambers. At 
least the tissue-imaging chamber of the bioreactor component 
is configured to be received within a magnetic resonance 
(MR) imager and includes at least one fiber optic sensor and 
fluidics capable of fluidly communicating with a source of 
oxygen. The Support chamber generally includes a heating 
element and fluidics capable offluidly communicating with at 
least one reservoir, where the Support chamber is configured 
to be able to comprise culture media and maintain the culture 
media under Suitable conditions. 
As described herein, the tissue imaging chamber is config 
ured to fall within the field-of-view (FOV) of the MR imager, 
and the support chamber is configured to fall outside the FOV 
of the MR imager. 
In some embodiments, the at least one fiber optic sensor is 
a temperature sensor. In some embodiments, the at least one 
fiber optic sensor is a CO2 sensor and/or a humidity sensor. In 
Some embodiments, the Support chamber further includes at 
least one non-fiber optic sensor. Representative non-fiber 
optic sensors include, for example, temperature sensors and/ 
or pH sensors. In some embodiments, the at least one non 
fiber optic sensor is in communication with a microcontroller. 
In some embodiments, the MRI-compatible bioreactor 
system further includes a pump configured to promote fluid 
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communication between the at least one reservoir and the 
culture media in the Support chamber. 
In some embodiments, a MRI-compatible bioreactor sys 
tem further can include a microcontroller. A microcontroller 
can be in communication with the at least one fiber optic 
sensor, with the heater, or with the at least one fiber optic 
sensor and the heater, where the at least one fiber optic sensor 
is a temperature sensor. 
In another aspect, a method of imaging a biological sample 
is provided. Such a method typically includes providing a 
MRI-compatible bioreactor system as described herein, 
where the tissue imaging chamber comprises a biological 
sample and the Support chamber comprises culture media; 
inserting at least the tissue imaging chamber of the bioreactor 
component into a MR imager such that the tissue imaging 
chamber falls within the field-of-view (FOV) of the MR 
imager and the support chamber does not fall within the FOV 
of the MR imager; and imaging the biological sample using 
the MR imager. 
The MRI-compatible bioreactor described herein can be 
inserted into the MR imager and imaged without disrupting 
the biological sample. In some embodiments, the methods 
include repeating the inserting and imaging steps at least 
twice, where repeating the inserting and the imaging steps at 
least twice does not require removing the biological sample or 
any portion thereof from the bioreactor and does not compro 
mise the biological sample or the culture media. In some 
embodiments, the methods include repeating the imaging 
step at least twice, where the inserting step is performed only 
OCC. 
In some embodiments, the methods also include exchang 
ing the media in the support chamber with fresh media in the 
at least one reservoir via the fluidics. In some embodiments, 
the methods further include repeating the exchanging step at 
least twice separated by a period of time. Periods of time can 
be, for example, hours, days, weeks, or months. 
As used herein, the biological sample refers to a tissue 
sample or a cell sample. 
Unless otherwise defined, all technical and scientific terms 
used herein have the same meaning as commonly understood 
by one of ordinary skill in the art to which the methods and 
compositions of matter belong. Although methods and mate 
rials similar or equivalent to those described herein can be 
used in the practice or testing of the methods and composi 
tions of matter, suitable methods and materials are described 
below. In addition, the materials, methods, and examples are 
illustrative only and not intended to be limiting. All publica 
tions, patent applications, patents, and other references men 
tioned herein are incorporated by reference in their entirety. 
DESCRIPTION OF DRAWINGS 
FIG. 1 shows a schematic of a representative MRI-com 
patible e-incubator. 
FIG. 2 shows the preliminary results of culturing osteo 
genic constructs in the e-incubator. Panel (a) shows an axial 
MRI of the chamber system, a 1.1 cm inner diameter tissue 
holder inside a 2.3 cm inner diameter TI chamber. Panel (b) 
and Panel (c) show axial MRIs at week-1 and week-2, respec 
tively, acquired by a fast spin-echo sequence with the same 
acquisition parameters; the in-plane resolution was 97 micron 
square. The construct position was slightly different from 
week-1 to week-2 due to media exchange. Panel (d) is a graph 
showing the 12-hour time course oftemperature (between 36 
to 37°C.) and CO (5%), where the sharp drops represent the 
event of media exchange every 6 hours. 
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Like reference symbols in the various drawings indicate 
like elements. 
DETAILED DESCRIPTION 
The design of the MRI-compatible bioreactor described 
herein is highly innovative. With an MRI-compatible cham 
ber designed for culturing cells and tissue, the bioreactor 
described herein is designed to integrate with a commercial 
MR imager, which can be used to assess the morphogenesis of 
developing tissue. 
Conventional tissue culture bioreactors typically restrict 
the ability to apply non-invasive medical imaging modalities. 
Hollow fiber bioreactors (HFBRs) are the only MRI-compat 
ible culture system (see, for example, Planchamp et al., 2004, 
Biotechnol. Bioeng, 85:656-65). However, HFBRs are lim 
ited by their lack of consistent physiological conditions inside 
HFBRs due to, for example, their requirement for constant 
media perfusion. In addition, conditions within HFBRs are 
not detectable or easily regulated during MRI acquisition; for 
example, in HFBRs, temperature is measured outside the 
magnet, which is not a faithful representation of the cells or 
tissues direct Surroundings. 
Compared to existing methodologies, the MRI-compatible 
bioreactor described herein offers an integrated approach that 
takes full advantage of high-resolution MRI, currently, the 
most Sophisticated clinically-viable imaging technique, by 
enabling dynamic assessment of developing constructs in a 
self-regulated and maintained culture environment. 
FIG. 1 shows one embodiment of a MRI-compatible biore 
actor system 1 as described herein. An MRI-compatible 
bioreactor system 1 includes a bioreactor 10. As used herein, 
a bioreactor (or bioreactor component) 10 refers to a device 
that Supports and maintains the viability of cells or tissues in 
culture and, in some instances, promotes the biological 
growth and/or development of the cells or tissues. In the 
embodiment shown in FIG. 1, the bioreactor component 10 is 
cylindrical, although any shape that a MR imager is capable 
of receiving is included herein. The bioreactor component 10 
can be divided into a tissue-imaging chamber 12 and a Sup 
port chamber 14, which are separated by a permeable Support 
structure 16. The permeable support structure 16 is one that 
allows for fluid communication between the tissue-imaging 
chamber 12 and the support chamber 14. 
In some embodiments, the tissue-imaging chamber 12 of 
the bioreactor component 10 is configured to be received 
within a magnetic resonance (MR) imager 50, while, in some 
embodiments, the entire bioreactor component 10 is config 
ured to be received within a MR imager 50. Even when the 
entire bioreactor component 10 is to be inserted within a MR 
imager 50, the tissue imaging chamber 12 is configured to fall 
within the field-of-view (FOV) of the MR imager 50, while 
the support chamber 14 is configured to fall outside the FOV 
of the MR imager 50. As such, the tissue-imaging chamber 12 
generally includes at least one fiber optic sensor 18, which is 
compatible with FOV MR imaging, while the support cham 
ber generally includes the culture media, which, as indicated 
herein, is in fluid communication with the tissue-imaging 
chamber 12 via the permeable support structure 16, a heating 
element 20 to maintain the proper temperature of the culture 
media, and fluidics 22 to be able to maintain the culture media 
under Suitable conditions. 
It would be understood that a heating element 20 in the 
support chamber 14 needs to be compatible with MR imag 
ing, but, since it falls outside of the FOV, does not need to be 
compatible with the actual imaging. Therefore, an example of 
a suitable heating element 20 is a ceramic heater. It would also 
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be understood that fluidics typically refers to at least some 
form of tubing that is capable of fluidly communicating with 
one or more components. In a MRI-compatible bioreactor 
system 1, fluidics 22 associated with the support chamber 14 
connect the support chamber 14 with at least one reservoir 24 
(e.g., to receive, provide, and/or exchange culture media). In 
some embodiments, a MRI-compatible bioreactor system 1 
can include at least two reservoirs 24; at least one reservoir 
24a to contain fresh media and at least one reservoir 24b to 
receive used or spent media during media exchange. In addi 
tion, to facilitate media exchange, a MRI-compatible biore 
actor system 1 optionally can include one or more pumps 26. 
In some embodiments, the at least one fiber optic sensor 18 
in the tissue-imaging chamber 12 is a temperature sensor. 
Having a temperature sensor in the tissue-imaging chamber 
12 allows for the temperature to be monitored, and modified 
if necessary, during all aspects of cell or tissue growth includ 
ing, for example, during the actual imaging. In addition or as 
an alternative to a temperature sensor, the fiber optic sensor 18 
in the tissue-imaging chamber 12 can be a CO sensor 28 
and/or a humidity sensor. In addition, a tissue-imaging cham 
ber 12 of a MRI-compatible bioreactor system 1 can include 
fluidics 30 for maintaining and/or changing the environment 
within the bioreactor. For example, fluidics 30 can connect 
the tissue-imaging chamber 12 with an appropriate source of 
air 32 (e.g., oxygen (O) and/or carbon dioxide (CO)) So as 
to properly oxygenate the culture. 
In some embodiments, the Support chamber 14 also 
includes at least one sensor 34. Since the Support chamber is 
configured to fall outside of the MRI FOV, sensors 34 that are 
located in the support chamber 14 do not need to be fiber 
optic. A sensor 34 located in the support chamber 14 can be, 
for example, a pH sensor and/or a temperature sensor. 
Since the bioreactor component of the MRI-compatible 
bioreactor system is configured to fit inside a MR imager and 
be imaged continually or at particular intervals, it would be 
understood by those skilled in the art that the components in 
the system that communicate and Support the bioreactor Such 
as, without limitation, an appropriate source of oxygen, one 
or more reservoirs, and/or one or more pumps, are exterior to 
the bioreactor component but remain in fluid communication 
with the bioreactor component via fluidics whether the biore 
actor component is inside or outside the imager. 
To sense and change the environment as necessary, a MRI 
compatible bioreactor system 1 as described herein also can 
include one or more microcontrollers 36. The one or more 
microcontrollers 36 can be in communication, for example, 
with the one or more fiber optic sensors 18 in the tissue 
imaging chamber 12 and/or with the heating element 20 and 
fluidics 22 in the support chamber 14. In embodiments in 
which the fiber optic sensor 18 in the tissue-imaging chamber 
12 is a temperature sensor, the microcontroller 36 also can be 
in communication with the heating element 20 in the Support 
chamber 14, such that the temperature of the culture media 
can be controlled and changed, as necessary or desired. In 
addition, a microcontroller 36 can be in communication with 
any additional sensors (e.g., fiber optic or non-fiber optic 
sensors) used to sense and/or control the environment in the 
bioreactor component 10. Further, a microcontroller 36 can 
be used in the process of media exchange (e.g., between the 
support chamber 14 of a bioreactor component 10 and one or 
more reservoirs 24 via, for example, one or more pumps 26). 
Conventionally, bone constructs are cultured in a CO 
incubator, which provides a Suitable environment maintained 
with respect to temperature, oxygen availability, and relative 
humidity. The MRI-compatible bioreactor system 1 
described herein is not just a replacement for conventional 
US 9,051,541 B2 
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incubators that includes automated media exchange, but the 
system described herein also offers a unique MR compatibil 
ity. The MRI-compatible bioreactor system 1 described 
herein provides a closely monitored and tightly controlled 
physiological environment for developing cell or tissue con 
structs inside an MRI, with continuous non-invasive assess 
ment of the morphogenesis evolution and functional outcome 
of the cell or tissue constructs through MRI. 
In the current design, MRI compatibility was incorporated 
because it is the most Sophisticated, clinically-viable, imag 
ing technique. With proper adjustments, the design can be 
modified to accommodate other imaging modalities such as 
Computed Tomography (CT). 
An MRI-compatible bioreactor system 1 as described 
herein can be used to image a biological sample growing in 
culture. Initially, a biological sample is deposited onto the 
permeable Support structure 16 and appropriate culture con 
ditions are established in the bioreactor 10. Appropriate cul 
ture conditions are known to those skilled in the art and 
typically include a culture media that provides the necessary 
components to keep alive the cells or tissues (e.g., required 
minerals, essential nutrients). The culture media also can 
provide one or more co-factors required by the cells or tissues. 
Appropriate culture conditions also include maintaining a 
proper temperature range and pH range. 
Appropriate culture conditions require that the culture 
media be changed periodically. For example, the spent media 
typically is replaced with fresh media so as to continue to 
Support the growth of the culture. The rate of media exchange 
is dependent upon the rate of growth of a particular organism 
or organisms but, under typical culture conditions, media is 
usually exchanged several times a day (e.g., every 2, 4, 6, 8 or 
10 hours), twice a day (e.g., about every 12 hours), at least 
once a day (e.g., every 18, 20, 22 or 24 hours), or more (e.g., 
every 30, 40 or 50 hours). In certain instances, the culture 
media in a bioreactor can be exchanged on a weekly basis or 
on a monthly basis. 
In Some embodiments, a feedback system can maintain the 
CO level in the tissue-imaging chamber using two flow con 
trollers to mix CO, and airbased on the value recorded by the 
CO sensor positioned on the output flow from the tissue 
imaging chamber. In addition, the quality of the media can be 
maintained by media exchange once every 6 hours, during 
which time, a pH sensor can determine the pH of the biore 
actor. Further, a humidity sensor also can be included in a 
MRI-compatible bioreactor system as described herein to 
maintain the proper humidity in the bioreactor. 
At any time after initiating the culture, at least the tissue 
imaging chamber of the bioreactor component can be inserted 
into a MR imager and imaged. As discussed herein, the biore 
actor component is inserted into the MR imager Such that the 
tissue imaging chamber falls within the field-of-view (FOV) 
of the MR imager and the support chamber falls outside the 
FOV of the MR imager. The biological sample can be imaged 
continuously for a period of time (e.g., several milliseconds, 
one or more seconds, one or more minutes, or longer) or at 
particular intervals (e.g., once every second, once every 
minute, multiple times per minute, several times per hour, or 
once or multiple times a week). It would be appreciated that 
the MRI-compatible bioreactor can be removed from the MR 
imager in between imaging, or it can remain inside the imager 
even when images are not being obtained. 
A biological sample contained within the MRI-compatible 
bioreactor system described herein can be imaged once or 
multiple times without compromising the sample. That is, 
none of the biological sample needs to be removed from the 
bioreactor prior to or during imaging, and the components 
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required for maintaining the viability of the culture are 
designed such that they do not interfere with the imaging 
process. Thus, the bioreactor remains a "closed’ system, even 
when introduced (and re-introduced) into an imager for imag 
ing. 
As used herein, the biological sample refers to any cell 
sample or any tissue sample. Representative cells include, 
without limitation, osteoblasts, osteoclasts, osteocytes, chon 
drocytes, hepatocytes, islet cells, myocytes, epithelial cells, 
kidney cells, and neurons, while representative tissues 
include, without limitation, bone, cartilage, liver, pancreas, 
muscle, epithelium, kidney, brain, uterus, ovarian, and testes. 
Simply by way of example, bone tissue engineering is 
emerging as a promising alternative for creating functional 
Substitutes for bone repair and replacement. Both autologous 
and allogeneic bone grafts are used clinically as bone Substi 
tutes; however, the availability of compatible grafts is limited 
because harvesting bone is painful and the procedure carries 
significant infection risks. Therefore, the MRI-compatible 
bioreactor described herein can be used to produce bone 
tissue. In addition, as tissue engineering grows in complexity 
to match the geometry and function of a patients unique 
needs, it becomes increasingly important to non-invasively 
follow the spatial and temporal pattern of growth and matu 
ration of the bone tissue in vitro. The MRI-compatible biore 
actor System described herein is expected to help produce 
tissue engineered bone constructs with proper osteogenic 
phenotype expression, which can expedite the clinical trans 
lation of bone tissue engineered products and improve the 
Success rate of bone transplantation. 
In accordance with the present invention, there may be 
employed conventional molecular biology, microbiology, 
biochemical, and recombinant DNA techniques within the 
skill of the art. Such techniques are explained fully in the 
literature. The invention will be further described in the fol 
lowing examples, which do not limit the scope of the methods 
and compositions of matter described in the claims. 
EXAMPLES 
Example 1 
Design and Configuration of a Prototype e-Incubator 
A basic prototype of a MRI-compatible bioreactor has 
been developed. Shown in FIG. 1, a cylindrical chamber 
system with an outer diameter of 3 cm was designed. Made of 
polycarbonate and manufactured by 3D printing, the system 
included a Support chamber and a tissue imaging (TI) cham 
ber. Tissue samples were positioned atop a permeable Support 
inside a tissue holder within the TI chamber. There were many 
challenges associated with MRI compatibility when imple 
menting the design. For example, in order to truthfully rep 
resent the sample's environmental condition, one design 
specification requires measuring and adjusting the tempera 
ture of the sample's direct surroundings with minimal MR 
susceptibility artifacts. Since the TI chamber is inside the 
MRI and, therefore, is encompassed by the MRI field-of-view 
(FOV), while the support chamber is outside the MRI and the 
MRI FOV, the solution used was to place a fiber optic tem 
perature probe (SA Instruments, Inc. Stony Brook, N.Y.) 
adjacent to the sample in the TI chamber (inside FOV) while 
regulating the temperature by an MR compatible ceramic 
heater located in the support chamber (outside FOV). 
For regulating all environmental conditions inside the TI 
chamber for biological samples, a Microchip PIC(R) MCU 
was used to operate a closed-loop feedback system via a C 
US 9,051,541 B2 
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program. By integrating both hardware and software, MCUs 
are embedded as “brains' in almost all “SMART devices, 
from consumer electronics to automobiles to medical sys 
tems. Physiological conditions inside the TI chamber were 
detected by physical and biochemical sensors and sent to the 
MCU. The MCU compared the received sensor signals with 
pre-determined thresholds and sent control signals to other 
mechatronics to guide their actions for adjusting those con 
ditions. For example, the MCU acquired data from the tem 
perature, CO., humidity sensors at a rate of one per ten 
seconds and the pH was evaluated during every media 
exchange. A peristaltic pump was used to exchange media 
based on the measured pH level; two flow controllers were 
used to mix air and CO to create proper concentration of CO. 
for the engineered tissues in the chamber. 
A preliminary study on human mesenchymal stem cells 
(hMSCs) derived osteogenic construct was performed using 
the MRI-compatible bioreactor prototype. For constructs 
preparation, human bone MSCs were isolated from fresh 
marrow cells provided commercially (Lonza, Walkersville, 
Md.). Upon 80% confluence, the hMSCs were trypsinized, 
counted, and passaged at a density 5x10 cells/cm and 
expanded in vitro. Expanded to passage 4-5, MSCs were 
re-Suspended and seeded into gelatin Sponges (Pharmacia & 
Upjohn, Kalamazoo, Mich.). Osteogenic medium (Xu et al., 
2006, Phys. Med. Biol., 51:719-32) was used to induce osteo 
genesis in the construct. FIG. 2 presents the data from this 
study. The viability and growth of the construct was validated 
with MRI results: lower signal intensity in construct at 
Week-2 compared to Week-1, Suggesting increased mineral 
ization and development of bone-like tissue FIG. 2(c) vs. 
FIG. 2(b). FIG. 2(d) shows automatic adjustments of the 
temperature (between 36 to 37°C.) and CO, level (5%) in the 
construct’s Surroundings. 
As described herein, the MRI-compatible bioreactor pro 
totype was integrated with a high resolution MRI scanner and 
TE bone constructs were successfully cultured for two weeks. 
The following Examples demonstrate that such a bioreactor 
can provide accurate controls to maintain the proper physi 
ological environment that is comparable to a conventional 
CO incubator. In addition, the following Examples demon 
strate that such a bioreactor truly is MRI compatible and 
enables prolonged growth (e.g., bone construct growth) to be 
continuously and non-invasively monitored. 
Example 2 
Verifying the Accuracy of the Operation of the 
MRI-Compatible Bioreactor 
Verifying that such a bioreactor can precisely control the 
internal environmental growth conditions for developing tis 
sue is required before placing a TE culture inside an MRI 
SCa. 
In order to create a reliable environment comparable to a 
conventional incubator, targeted operating parameters for the 
bioreactor are 37°C., 5% CO level, and 95% relative humid 
ity. Regular media exchange is performed for maintaining 
proper pH level. Prior to loading biological samples into the 
bioreactor, all components are dissembled. All relevant com 
ponents inside the TI chamber are cleaned with Alcon, soaked 
in 1M NaOH for an hour, and then rinsed twice with sterile 
water, to eliminate possible contamination. 
Two types of biological samples were tested: 
Standard culture media as a phantom for verifying the 
accuracy of adjusting physiological conditions and 
examining possible contamination inside the bioreactor. 
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The phantom is tested in the bioreactor for one week, 
during which time, the temperature, CO, and humidity 
conditions are recorded at a rate of one per ten seconds 
and the pH evaluated for every media exchange (sched 
uled once every 6 hours). The starting and ending times 
of each media exchange are recorded. Used media is 
examined under an inverted microscope for contamina 
tion. This experiment is repeated twice, and, before 
starting the second set of experiments, the bioreactor is 
dissembled, cleaned, reset, and filled with fresh standard 
culture media. 
TE bone constructs for confirming that the e-incubator 
provides a Suitable environment for engineered tissues. 
ATE osteogenic construct of size 4 mmx4mmx4 mm is 
prepared as described in Example 1 and placed inside 
the TI chamber for four weeks atop the permeable Sup 
port. In addition to recording physiological conditions 
as descried above, following four weeks of constructs 
culture in the bioreactor, constructs are fixed with 10% 
neutral buffered formalin and sectioned. This experi 
ment is repeated twice as well. In order to confirm the 
viability of the TE bone constructs, at the end of each 
experiment, sections are stained with hematoxylin and 
eosin (H&E) and Von Kossa to examine mineralization 
and calcium deposition. In parallel to the experiments 
conducted in the bioreactor, threeTE bone constructs are 
cultured in a conventional incubator. After four weeks of 
culture, all samples in the conventional incubator are 
fixed and undergo similar histological analysis. 
All data collected from above experiments, i.e., three sets 
of one-week phantom data and three sets of four-week TE 
construct data, are analyzed statistically to testify the accu 
racy of bioreactor operation: 
For each media exchange, the mean time duration required 
for temperature, CO, and humidity to return to normal oper 
ating mode are computed based on the average difference of 
the end and starting times. For all the raw data, data points 
recorded during media exchange are filtered and the rest of 
the data represents normal operating mode of the bioreactor. 
For each physiological parameter in each individual set of 
experiment, e.g., temperature, CO level, or humidity, the 
mean and standard deviation of measurements during the 
normal operating mode are computed. 
The following criteria are used to determine if the bioreac 
tor performance is adequate. 
All of the physiological parameters should return to the 
normal operating mode within 5 minutes, which is deter 
mined based on the time it takes for a tissue engineer to 
exchange the media. The bioreactor is considered satis 
factory if the confidence level is at least 95% that, every 
time, the duration is less than 5 minutes. 
The bioreactor is considered accurate if the confidence 
level is at least 95% that every temperature measurement 
is within 1% of 37°C., and every CO/humidity mea 
surement is within 5% of its respective target. 
For each individual parameter, the means and standard 
deviations of one-week phantom are compared to those 
of four-week TE constructs to determine if there is sig 
nificant difference with respect to the biological sample 
and the length of time it is cultured in the bioreactor. 
Histological review of TE constructs cultured both in the 
bioreactor and the conventional incubator are performed 
in a blinded study by a Board-certified pathologist for 
assessing possible variation in construct development 
between a conventional incubator and the bioreactor. 
All physiological conditions of the tissue sample's Sur 
roundings are closely monitored and properly regulated 
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autonomously via a closed-loop system. Preliminary studies 
indicate that the bioreactor performs better than or at least 
comparable to conventional incubators, likely due to reduced 
human handling (i.e., transferring the samples in a biosafety 
cabinet to perform media exchange is no longer needed). 
Example 3 
Validating the Ability of the e-Incubator in Culturing 
Bone Constructs Using Quantitative MRI 
Using engineered bone, an MRI-compatible bioreactor 
facilitates non-invasive high-resolution imaging for the con 
tinuous evaluation of the constructs concurrent with in vitro 
tissue development. 
In order to confirm that the bioreactor mechatronics inside 
the magnet are MRI-compatible and do not affect MRI sen 
sitivity in detecting bone formation, engineered bone con 
structs were used. In order to take advantage of the bioreac 
tor's capability of culturing tissue samples non-interruptedly, 
the tissue holder of the bioreactor is revised to include fine 
grids so that five samples can be cultured and assessed simul 
taneously. Constructs cultured in a conventional incubator are 
labeled “incubator group and constructs in the bioreactor are 
labeled “e-incubator' group. 
Thirty TE bone constructs of size 3 mmx3 mmx3 mm are 
prepared with the procedures described in Example 1. On 
Day 0, constructs are divided into two groups: twenty five 
“incubator bone constructs and five “e-incubator bone con 
structs. All five “e-incubator bone constructs are loaded in 
the tissue holder of the bioreactor and then the 3 cm cylindri 
cal chamber system is inserted into a 4 cm Millipede radiof 
requency (RF) imaging probe of a 9.4T (400 MHz for pro 
tons) 89 mm vertical bore MRI scanner (Agilent, Santa Clara, 
Calif.), equipped with 100 G/cm maximum triple axis gradi 
ents. The entire construct is divided as six axial slices with a 
thickness of 500 um and a spatial resolution of 100 umx100 
um. For MRI acquisitions, MR spin-spin relaxation time (T) 
is measured by applying a spin echo imaging sequence to 
acquire 32 echoes with 4 seconds of repetition time (TR) and 
8 milliseconds echo spacing (TE). These measurements are 
acquired on a daily basis. For the twenty five “incubator 
bone constructs, TE samples are allocated into a test tube and 
subjected to MRI. Since it is not possible to perform daily 
MRI with a conventional incubator; measurements are 
acquired only at five discrete time points, i.e., Day 0, 7, 14, 21. 
and 28, with five samples at each specific time point. At the 
end of tissue culture, i.e., Day 28, five remaining “incubator 
samples and all five “e-incubator” samples are fixed and 
Subjected to histological analysis. These experiments are 
repeated on control constructs prepared only with basic cul 
ture media. Because the controls are not expected to develop, 
no matter in a conventional or the bioreactor, MRI only is 
acquired at specified time points for both “incubator' and 
“e-incubator groups. 
The effectiveness of the bioreactor on growing osteogenic 
constructs inside a MRI scanner is quantified by statistical 
analysis. For quantitative MRI analysis, the T relaxation 
time is analyzed using a mono-exponential model and 
mapped for the entire construct using a custom developed 
MATLAB program. Based on preliminary results, the mean 
value of the T in bone constructs is expected to exhibit a 
greater than 50% reduction after 4 weeks in culture, while the 
control constructs show no significant difference in T with 
time (Xu et al., 2006, Phys. Med. Biol., 51:719-32). The 
bioreactor is validated when statistical tests on T. reject the 
hypotheses that (i) the mean value of “e-incubator bone 
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constructs is greater than or equal to that of “incubator bone, 
(ii) the variance of “e-incubator bone constructs is greater 
than or equal to that of “incubator bone, and (iii) the mean 
value of “e-incubator” control constructs is different than that 
of “incubator control. Histological analysis is used as a 
reference to confirm bone formation in TE bone constructs. 
The use of a detailed imaging assessment technique pro 
vided by MRI-integrated bioreactor will allow the production 
of high quality TE constructs, to thereby improve the Success 
rate of bone replacement implantation. In some instances, the 
bioreactor would only be placed inside the magnetic field 
during MRI sessions, since the effect of a strong magnetic 
field on engineered tissues growth is not well understood. 
Also, recent advances such as Zero echo time MRI may be 
useful, for example, to study late growth stages of osteogen 
esis, since intensive mineralization may hamper conventional 
MRI. 
It is to be understood that, while the methods and compo 
sitions of matter have been described herein in conjunction 
with a number of different aspects, the foregoing description 
of the various aspects is intended to illustrate and not limit the 
scope of the methods and compositions of matter. Other 
aspects, advantages, and modifications are within the scope of 
the following claims. 
Disclosed are methods and compositions that can be used 
for, can be used in conjunction with, can be used in prepara 
tion for, or are products of the disclosed methods and com 
positions. These and other materials are disclosed herein, and 
it is understood that combinations, Subsets, interactions, 
groups, etc. of these methods and compositions are disclosed. 
That is, while specific reference to each various individual 
and collective combinations and permutations of these com 
positions and methods may not be explicitly disclosed, each is 
specifically contemplated and described herein. For example, 
if a particular composition of matter or a particular method is 
disclosed and discussed and a number of compositions or 
methods are discussed, each and every combination and per 
mutation of the compositions and the methods are specifically 
contemplated unless specifically indicated to the contrary. 
Likewise, any Subset or combination of these is also specifi 
cally contemplated and disclosed. 
What is claimed is: 
1. An MRI-compatible bioreactor System, comprising: 
a bioreactor comprising a tissue-imaging chamber and a 
Support chamber that are separated by a permeable Sup 
port that allows for fluid communication between the 
chambers, wherein at least the tissue-imaging chamber 
of the bioreactor component is configured to be received 
within a magnetic resonance (MR) imager; 
wherein the tissue-imaging chamber comprises at least one 
fiber optic sensor and fluidics capable of fluidly commu 
nicating with a source of oxygen, wherein the tissue 
imaging chamber is configured to fall within the field 
of-view (FOV) of the MR imager; and 
wherein the Support chamber comprises a heating element 
and fluidics capable of fluidly communicating with at 
least one reservoir, wherein the Support chamber is con 
figured to comprise culture media and maintain the cul 
ture media under Suitable conditions, wherein the Sup 
port chamber is configured to fall outside of the FOV of 
the MR imager. 
2. The bioreactor system of claim 1, wherein the at least 
one fiber optic sensor is a temperature sensor. 
3. The bioreactor system of claim 1, further comprising a 
microcontroller in communication with the at least one fiber 
optic sensor. 
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4. The bioreactor System of claim 1, further comprising a 
microcontroller in communication with the heater. 
5. The bioreactor system of claim 1, further comprising a 
microcontroller in communication with the at least one fiber 
optic sensor and the heater, wherein the at least one fiber optic 
sensor is a temperature sensor. 
6. The bioreactor system of claim 1, wherein the support 
chamber further comprises at least one non-fiber optic sensor. 
7. The bioreactor system of claim 6, wherein the at least 
one non-fiber optic sensor is selected from the group consist 
ing of a temperature sensor and a pH sensor. 
8. The bioreactor system of claim 6, wherein the at least 
one non-fiber optic sensor is in communication with a micro 
controller. 
9. The bioreactor system of claim 1, further comprising a 
pump configured to promote fluid communication between 
the at least one reservoir and culture media in the Support 
chamber. 
10. A method of imaging a biological sample, comprising: 
providing the MRI-compatible bioreactor system of claim 
1, wherein the tissue imaging chamber comprises a bio 
logical sample and the Support chamber comprises cul 
ture media; 
inserting at least the tissue imaging chamber of the biore 
actor component into a MR imager Such that the tissue 
imaging chamber falls within the field-of-view (FOV) of 
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the MR imager and the support chamber does not fall 
within the FOV of the MR imager; and 
imaging the biological sample using the MR imager. 
11. The method of claim 10, wherein the biological sample 
is a tissue sample or a cell sample. 
12. The method of claim 10, further comprising repeating 
the inserting and imaging steps at least twice. 
13. The method of claim 12, wherein repeating the insert 
ing and the imaging steps at least twice does not require 
removing the biological sample or any portion thereof from 
the bioreactor. 
14. The method of claim 12, wherein repeating the insert 
ing and the imaging steps at least twice does not compromise 
the biological sample or the culture media. 
15. The method of claim 10, further comprising repeating 
the imaging step at least twice, wherein the inserting step is 
performed only once. 
16. The method of claim 10, further comprising exchang 
ing the media in the support chamber with fresh media in the 
at least one reservoir via the fluidics. 
17. The method of claim 16, further comprising repeating 
the exchanging step at least twice separated by a period of 
time. 
18. The method of claim 17, wherein the period of time is 
selected from the group consisting of hours, days, weeks, and 
months. 
